desipramine has been researched along with Protein Aggregation, Pathological in 1 studies
Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.
Protein Aggregation, Pathological: A biochemical phenomenon in which misfolded proteins aggregate either intra- or extracellularly. Triggered by factors such as MUTATION; POST-TRANSLATIONAL MODIFICATIONS, and environmental stress, it is generally associated with ALZHEIMER DISEASE; PARKINSON DISEASE; HUNTINGTON DISEASE; and TYPE 2 DIABETES MELLITUS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pérez-Areales, FJ | 1 |
| Di Pietro, O | 1 |
| Espargaró, A | 1 |
| Vallverdú-Queralt, A | 1 |
| Galdeano, C | 1 |
| Ragusa, IM | 1 |
| Viayna, E | 1 |
| Guillou, C | 1 |
| Clos, MV | 1 |
| Pérez, B | 1 |
| Sabaté, R | 1 |
| Lamuela-Raventós, RM | 1 |
| Luque, FJ | 1 |
| Muñoz-Torrero, D | 1 |
1 other study available for desipramine and Protein Aggregation, Pathological
| Article | Year |
|---|---|
Shogaol-huprine hybrids: dual antioxidant and anticholinesterase agents with β-amyloid and tau anti-aggregating properties.
Topics: Acetylcholinesterase; Aminoquinolines; Amyloid beta-Peptides; Antioxidants; Catechols; Cholinesteras | 2014 |